ROS-Responsive N-Alkylaminoferrocenes for Cancer-Cell-Specific Targeting of Mitochondria
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ROS-Responsive N-Alkylaminoferrocenes for Cancer-Cell-Specific Targeting of Mitochondria
Authors
Keywords
-
Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 57, Issue 37, Pages 11943-11946
Publisher
Wiley
Online
2018-07-23
DOI
10.1002/anie.201805955
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tuning the structure of aminoferrocene-based anticancer prodrugs to prevent their aggregation in aqueous solution
- (2018) Steffen Daum et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- The medicinal chemistry of ferrocene and its derivatives
- (2017) Malay Patra et al. Nature Reviews Chemistry
- Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria
- (2016) Sae Rin Jean et al. ACCOUNTS OF CHEMICAL RESEARCH
- Base-Resolution Analysis of Cisplatin-DNA Adducts at the Genome Scale
- (2016) Xiaoting Shu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A review of monoclonal antibody therapies in lymphoma
- (2016) Esmeralda Chi-yuan Teo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?
- (2016) Gianantonio Rosti et al. Nature Reviews Clinical Oncology
- Ferrocifen type anti cancer drugs
- (2015) Gérard Jaouen et al. CHEMICAL SOCIETY REVIEWS
- Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents
- (2015) Josephine Modica-Napolitano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Catalytically Generated Ferrocene-Containing Guanidines as Efficient Precursors for New Redox-Active Heterometallic Platinum(II) Complexes with Anticancer Activity
- (2015) Daniel Nieto et al. ORGANOMETALLICS
- A novel cyclometallated Pt(ii)–ferrocene complex induces nuclear FOXO3a localization and apoptosis and synergizes with cisplatin to inhibit lung cancer cell proliferation
- (2014) Roldán Cortés et al. Metallomics
- Detouring of cisplatin to access mitochondrial genome for overcoming resistance
- (2014) S. Marrache et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Mitochondrial DNA with a Platinum-Based Anticancer Agent
- (2013) Simon P. Wisnovsky et al. CHEMISTRY & BIOLOGY
- Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma
- (2013) Steven J. O'Day et al. JOURNAL OF CLINICAL ONCOLOGY
- Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia
- (2012) A. Wiestner BLOOD
- ROS-Inducible DNA Cross-Linking Agent as a New Anticancer Prodrug Building Block
- (2012) Sheng Cao et al. CHEMISTRY-A EUROPEAN JOURNAL
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Synthesis and Selective Anticancer Activity of Organochalcogen Based Redox Catalysts
- (2010) Mandy Doering et al. JOURNAL OF MEDICINAL CHEMISTRY
- Organometallic Anticancer Compounds
- (2010) Gilles Gasser et al. JOURNAL OF MEDICINAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started